Melanocyte stimulating hormone (MSH) enhances melanization but inhibits proliferation of Cloudman S91 melanoma cells in culture. We have isolated variants of these cells that can grow in the presence of MSH. The conclusions we have reached from analyses of these cells are the following: (1) Basal tyrosinase activity (monophenol monooxygenase; monophenol, dihydroxyphenylalanine:oxygen oxidoreductase, EC 1.14.18.1), i.e., the activity that is present in the absence of added MSH, is related through a common biochemical pathway to MSH-mediated control of growth. (2) MSH-inducible tyrosinase activity does not appear to be related to MSH control of growth. (3) The morphological changes that occur following the addition of MNSH or cAMP are related to controls of growth and not to those of melanization.
Melanocyte stimulating hormone (MSH) enhances melanization but inhibits the proliferation of cells from the Cloudman S91 mouse melanoma in culture (1) . Both effects result from an increase in the intracellular levels of cyclic AMP which occurs within minutes after the addition of MSH to the cultures (1) (2) (3) .
The concentration of cyclic AMP inside a cell is crucial to the control of proliferation of that cell (4) . For example, rapidly dividing cells generally have lower levels of cyclic AMP than slowly dividing or stationary cells (5) (6) (7) (8) (9) ; some tumor viruses bring about a rapid drop in cyclic AMP in normal cells before the cells undergo. a malignant transformation (10, 11) ; and a wide variety of transformed cells appear to revert to normal when cyclic AMP or one of its analogues is added to the medium of the cells in culture (1, (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) , or injected into animals harboring tumors of those cells (25, 26) . However, little is known of the mechanisms in the control processes. Daniel et al. (27) and Sibley et al. (28) selected for mutant mouse lymphoma cells that could grow in concentrations of cyclic AMP that were lethal to the wildtype cells. By analyzing these mutants they hope to find out more about the role of cyclic AMP in the control of growth. Similarly, we have isolated and studied clones of melanoma cells that are resistant to the inhibitory effects of MSH on growth. In this report we describe experiments which clarify the relationships of cyclic AMP to the control of both the growth and melanization of these cells.
METHODS
Isolation of MSH-Resistant Cells. Cells were cultured in a manner described previously (29) (33) . DNA was determined by the method of Burton (34) .
RESULTS
Effects of MSH on the Proliferation of Cells. We compared the amount of D)NA in cells blocked by MSH, blocked in metaphase by colchicine, and those growing normally (Table   1) . There was about one-half as much 1)NA in the cells blocked by MSH as in the cells in metaphase that were blocked by colchicine. Except for the possibility that MSII reduced cellular ploidy, these findings indicated that MSH inhibits proliferation in the G-1 or early S phase of the cell cycle.
Growth Characteristics. Clone mel-i had very low basal tyrosinase activity and was amelanotic in the absence of MSH, but showed a striking risein tyrosinase activity and melanin content following the addition of MSH or Bt2cAMP to the culture medium. In this respect mel-i was similar to amelanotic cell lines that were described previously (29) . The loss of basal tyrosinase activity and melanin content was not expected because we selected only for resistance to MSH inhibition of growth. This result implied that a relationship existed between resistance to MSH in the control of growth and loss of basal tyrosinase activity. Tor test whether or not such a relationship was real we examined four clones which had previously been selected for loss of basal melanization but not for MSH resistance in growth (29) . Three of the four clones were MSH-resistant in growth (Table 4) , although like clone mel-i they responded to MSH by showing an increase in tyrosinase activity and melanin content (29) . Because the loss of basal activity and the acquisition of MSH resistance are both rare events, it appears unlikely that the presence of both traits in cells selected for either one or the other was coincidental. The most likely explanation for these results is that there is a biochemical relationship between resistance to MSH inhibition of growth and basal tyrosinase activity. However, since one of the four clones (PS 4-51) that was selected for loss of basal activity was still sensitive to MSH inhibition of growth, the relationship between growth inhibition and basal tyrosinase activity is not necessarily an obligatory one.
Morphology. MSH or Bt2cAMP caused wild-type cells to become flattened and more dendritic in shape, but had no effect on either clone amel-1 or mel-i (Fig. 2) Cells (106) were inoculated into 30 ml Falcon tissue culture flasks and grown in normal medium or medium supplemented with MSH (0.2 uM). After 14 days the cells were harvested and counted in a Coulter counter. The results represent averages of duplicate culture flasks. These cell lines were described in a previous publication (29) but in that study the effects of MSH on proliferation were not determined.
in each case; (3) the number of receptors was of the same order in each case but, amel-1 and mel-i cells consistently had about two times more receptor activity than wild-type cells; and (4) when Bt2cAMP was added to the culture medium, receptor activity was increased in wild-type and mel-i cells but was usually decreased in amel-i cells. Bt2cAMP did not change the percentage of receptor-bearing cells in the population (Table 6) .
Protein Kinase Activity and Cyclic AMP Binding Proteins. Cells from all three lines had about the same levels of cAMPdependent protein kinase activity and proteins that bound cAMP ( Table 7) .
Transport of cAMP from the Culture Medium into the Cells. The appearance of MSH-resistant clones in the population is a rare event and we do not yet know its frequency. Our Varga and Pawelek (manuscript in preparation) proposed an explanation for this phenomenon based upon the observations that cultured Cloudman melanoma cells do not exhibit MSH receptor activity throughout the cell cycle but rather restrict the availability of receptors to the G-2 phase (34). We could explain how cells escape the proposed "G-1 restriction point common to normal nonproliferating-cells" (37) . Perhaps MSH receptor activity is discontinuous throughout the cycle so that intracellular cAMP levels are low during periods of DNA synthesis and high during periods of melanization. Thus, cells could escape specific restriction points by the discontinuous reception of signals.
However, the reason melanoma cells in culture become blocked after one or two cell divisions remains unclear (Fig.  la) . Perhaps the cells in culture are unable to release the MSH once it is bound to them in the G-2 phase and they become restricted when they traverse the cycle to G-1 again.
It is obvious from the analyses of these cells that the control of their phenotypic expression is of a high order of complexity. HoweVer, we believe that the further isolation and analysis of mutants, and particularly the achievement of genetic complementation between them should be of great use in understanding some of the control mechanisms that are involved.
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